| IRONWOOD PHARMA.A DL-,001 |
| USA |
| Gesundheit |
| US46333X1081 / A0X789 |
| I76 (Frankfurt) / IRWD (NASDAQ) |
| FRA:I76, ETR:I76, I76:GR, NASDAQ:IRWD |
| - |
| http://www.ironwoodpharma.. |
|
Ironwood Pharmaceuticals Inc. is a healthcare and pharmaceuticals company specializing in the development and commercialization of drugs for gastrointestinal conditions. Headquartered in Cambridge, Massachusetts, Ironwood focuses on designing novel t..
>Volltext.. |
| 554.4 Mio. EUR |
| 880.57 Mio. EUR |
| 310.6 Mio. EUR |
| 175 Mio. EUR |
| 87.78 Mio. EUR |
| 0.54 EUR |
| 513.22 Mio. EUR |
| 189.42 Mio. EUR |
| - |
| 0.93 |
| 6.56% |
| - |
| - |
| - |
| - |
| - |
| IRONWOOD |
| 27.05.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|